197 related articles for article (PubMed ID: 34115234)
21. Association of vascular endothelial growth factor and renal thrombotic microangiopathy-like lesions in patients with Castleman's disease.
Sun PP; Yu XJ; Wang SX; Zhou XJ; Qu L; Zhang F; Ma YY; Liu G; Yang L
Nephrology (Carlton); 2020 Feb; 25(2):125-134. PubMed ID: 31264312
[TBL] [Abstract][Full Text] [Related]
22. Complement Factor C4d Is a Common Denominator in Thrombotic Microangiopathy.
Chua JS; Baelde HJ; Zandbergen M; Wilhelmus S; van Es LA; de Fijter JW; Bruijn JA; Bajema IM; Cohen D
J Am Soc Nephrol; 2015 Sep; 26(9):2239-47. PubMed ID: 25573909
[TBL] [Abstract][Full Text] [Related]
23. Anti-VEGF-related thrombotic microangiopathy in a child presenting with nephrotic syndrome.
Yılmaz S; Özçakar ZB; Taktak A; Kiremitçi S; Ensari A; Dinçaslan H; Yalçınkaya F
Pediatr Nephrol; 2016 Jun; 31(6):1029-32. PubMed ID: 26928310
[TBL] [Abstract][Full Text] [Related]
24. Expression patterns of RelA and c-mip are associated with different glomerular diseases following anti-VEGF therapy.
Izzedine H; Mangier M; Ory V; Zhang SY; Sendeyo K; Bouachi K; Audard V; Péchoux C; Soria JC; Massard C; Bahleda R; Bourry E; Khayat D; Baumelou A; Lang P; Ollero M; Pawlak A; Sahali D
Kidney Int; 2014 Feb; 85(2):457-70. PubMed ID: 24067439
[TBL] [Abstract][Full Text] [Related]
25. Crim1KST264/KST264 mice implicate Crim1 in the regulation of vascular endothelial growth factor-A activity during glomerular vascular development.
Wilkinson L; Gilbert T; Kinna G; Ruta LA; Pennisi D; Kett M; Little MH
J Am Soc Nephrol; 2007 Jun; 18(6):1697-708. PubMed ID: 17460146
[TBL] [Abstract][Full Text] [Related]
26. Advances in our understanding of the pathogenesis of glomerular thrombotic microangiopathy.
Keir L; Coward RJ
Pediatr Nephrol; 2011 Apr; 26(4):523-33. PubMed ID: 20949284
[TBL] [Abstract][Full Text] [Related]
27. Genetic background-dependent thrombotic microangiopathy is related to vascular endothelial growth factor receptor 2 signaling during anti-glomerular basement membrane glomerulonephritis in mice.
Mesnard L; Cathelin D; Vandermeersch S; Rafat C; Luque Y; Sohier J; Nochy D; Garcon L; Callard P; Jouanneau C; Verpont MC; Tharaux PL; Hertig A; Rondeau E
Am J Pathol; 2014 Sep; 184(9):2438-49. PubMed ID: 25005449
[TBL] [Abstract][Full Text] [Related]
28. Vascular endothelial growth factor receptor 2 direct interaction with nephrin links VEGF-A signals to actin in kidney podocytes.
Bertuccio C; Veron D; Aggarwal PK; Holzman L; Tufro A
J Biol Chem; 2011 Nov; 286(46):39933-44. PubMed ID: 21937443
[TBL] [Abstract][Full Text] [Related]
29. Renal thrombotic microangiopathy during nintedanib treatment for idiopathic pulmonary fibrosis
.
Inoue D; Nishi H; Honda K; Ishii T; Abe H; Sato M; Nangaku M
Clin Nephrol; 2020 Jan; 93(1):47-50. PubMed ID: 31699213
[TBL] [Abstract][Full Text] [Related]
30. Biology of anti-angiogenic therapy-induced thrombotic microangiopathy.
Eremina V; Quaggin SE
Semin Nephrol; 2010 Nov; 30(6):582-90. PubMed ID: 21146123
[TBL] [Abstract][Full Text] [Related]
31. Nintedanib-induced glomerular microangiopathy: a case report.
Hasegawa M; Uehara A; Suzuki T; Sekine R; Yazawa M; Ichikawa D; Koike J; Shibagaki Y
CEN Case Rep; 2020 Nov; 9(4):295-300. PubMed ID: 32279192
[TBL] [Abstract][Full Text] [Related]
32. Effects of podocyte injury on glomerular development.
Ma J; Rossini M; Yang HC; Zuo Y; Fogo AB; Ichikawa I
Pediatr Res; 2007 Oct; 62(4):417-21. PubMed ID: 17667850
[TBL] [Abstract][Full Text] [Related]
33. VEGF signalling inhibition-induced proteinuria: Mechanisms, significance and management.
Izzedine H; Massard C; Spano JP; Goldwasser F; Khayat D; Soria JC
Eur J Cancer; 2010 Jan; 46(2):439-48. PubMed ID: 20006922
[TBL] [Abstract][Full Text] [Related]
34. All anti-vascular endothelial growth factor drugs can induce 'pre-eclampsia-like syndrome': a RARe study.
Vigneau C; Lorcy N; Dolley-Hitze T; Jouan F; Arlot-Bonnemains Y; Laguerre B; Verhoest G; Goujon JM; Belaud-Rotureau MA; Rioux-Leclercq N
Nephrol Dial Transplant; 2014 Feb; 29(2):325-32. PubMed ID: 24302609
[TBL] [Abstract][Full Text] [Related]
35. Vascular endothelial growth factor enhances glomerular capillary repair and accelerates resolution of experimentally induced glomerulonephritis.
Masuda Y; Shimizu A; Mori T; Ishiwata T; Kitamura H; Ohashi R; Ishizaki M; Asano G; Sugisaki Y; Yamanaka N
Am J Pathol; 2001 Aug; 159(2):599-608. PubMed ID: 11485918
[TBL] [Abstract][Full Text] [Related]
36. Renal Pathologic Findings in TAFRO Syndrome: Is There a Continuum Between Thrombotic Microangiopathy and Membranoproliferative Glomerulonephritis? A Case Report and Literature Review.
Leurs A; Gnemmi V; Lionet A; Renaud L; Gibier JB; Copin MC; Hachulla E; Hatron PY; Launay D; Fajgenbaum D; Terriou L
Front Immunol; 2019; 10():1489. PubMed ID: 31316523
[No Abstract] [Full Text] [Related]
37. PDGF-C mediates glomerular capillary repair.
Boor P; van Roeyen CR; Kunter U; Villa L; Bücher E; Hohenstein B; Hugo CP; Eriksson U; Satchell SC; Mathieson PW; Eitner F; Floege J; Ostendorf T
Am J Pathol; 2010 Jul; 177(1):58-69. PubMed ID: 20489153
[TBL] [Abstract][Full Text] [Related]
38. The Detection of Urinary Podocytes from Drug-Induced Glomerular Thrombotic Microangiopathy in Advanced Cancer Patients.
Usui J; Yokoyama C; Hagiwara M; Hirayasu K; Kojima T; Yoshino T; Nishiyama H; Hara M; Yamagata K
Clin Lab; 2016 Dec; 62(12):2413-2417. PubMed ID: 28164557
[TBL] [Abstract][Full Text] [Related]
39. The Accumulation of VEGFA in the Glomerular Basement Membrane and Its Relationship with Podocyte Injury and Proteinuria in Alport Syndrome.
Wang H; Yue Z; Wu J; Liu T; Mo Y; Jiang X; Sun L
PLoS One; 2015; 10(8):e0135648. PubMed ID: 26274923
[TBL] [Abstract][Full Text] [Related]
40. Surufatinib-induced renal thrombotic microangiopathy: first case report and review of literature.
Zhu W; Wang W; Shi Y; Shen B; Li Y
Virchows Arch; 2023 Oct; 483(4):561-567. PubMed ID: 37101053
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
